NL-OMON23089招募中不适用
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT
Erasmus Medical Center Rotterdam0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 6 to 18 years
- •Documented clinical diagnosis of autism spectrum disorder according to DSM IV or DSM V and comorbid behavioural problems
- •To start treatment with risperidone
排除标准
- •Diabetes type I or II
- •Congenital or acquired syndrome associated with changes in appetite, body weight or lipid profile (e.g. Prader Willi)
- •Treatment with antipsychotic medication within the last 6 months
- •Known Long QT syndrome (LQTS)
研究者
相似试验
已完成
不适用
Safety and pharmacokinetics of antipsychotics in children with autismAutism Spectrum Disorder (autisme spectrum stoornis)NL-OMON22814Erasmus Medical Center Rotterdam90
已完成
不适用
Safety and pharmacokinetics of antipsychotics in children with autismbehavioral disturbances10034726autismNL-OMON47545Erasmus MC, Universitair Medisch Centrum Rotterdam150
进行中（未招募）
1 期
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCTAutism spectrum disorderCTIS2024-511568-96-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)280
尚未招募
3 期
Effect of different antipsychotic medications on craving and craving related brain activity in patients with schizophrenia and cannabis abuse or dependence: a randomized controlled study comparing clozapine and risperidoneverslavingpsychotic disorders10039628schizophreniaNL-OMON32193Academisch Medisch Centrum70
尚未招募
不适用
To study and compare the side effects of one drug vs more than one drug in the treatment for schizophrenia.CTRI/2022/12/048297Department of psychiatry